Daily price updates
What planify offer?
Join our channel partner program
Content
Discover and get a
complete analysis on East India
Pharmaceutical Works Limited - Management,
Business Model, Financials, Growth, Valuations, Funding Rounds, News and get
the latest updates on East
India Pharmaceutical Upcoming IPO.
ISIN
INE254X01017
Face Value
₹10.00
Total Income
₹17,269.64 L
Profit After Tax
₹314.85 L
EPS
₹4.72
P/E
19.07
P/B
1.28
Market Capitalisation
₹60.07 Cr
Enterprise Value
₹74.71 Cr
Book Value
₹70.29
Dividend Yield
1.39 %
Earnings Yield
5.24 %
Sector
Health Care
Sub-sector
Pharmaceuticals
Category
Micro Cap
Cashflow - Operations
₹759.35 L
Cashflow - Financing
-₹395.98 L
Compounded Sales Growth
9.02%
1 Year
4.41%
3 Year
3.56%
4 Year
Compounded Profit Growth
56.88%
1 Year
66.56%
3 Year
13.47%
4 Year
Return On Equity
6.71%
2021
4.47%
2020
1.60%
2018
Overview:
Therapies
Analgesic- Antipyretic
Antibiotic
Antiprotozoal
Antivirus
Cough Syrup
Decongestant
Digestive Aid
Haematinic
Injectable
Ophthalmic
Probiotic
Vitamins
Herbals
Cough Syrup
Gynaecologist
Hepatoprotective
Metabolic
Urological
Introduction:
Company’s Solvency Ratio is quite decent at its own, but in comparison to peers it’s a little low that needs to be improvement.
Healthcare market in India is expected to reach USS 193.83 billion by 2020 and USS 372 billion by 2022, driven by rising income, better health awareness, lifestyle diseases and increasing access to insurance.
The Government of India aims to increase healthcare spending to 3% of the Gross Domestic Product (GDP) by 2022.
The healthcare landscape continues to evolve, with regulatory changes and scrutiny on the rise. This trend continues due to pressure to reduce regulation and control regulatory costs.
RECOMMENDATION
Buy
Industry Statistics
PUBLIC LIMITED
Registered In
India
last Updated
12/09/2021
Registered Date
27/04/1936
Planify Ticker
esdsd
Reg Office: 6, Nandalal Bose Sarani, Kolkata 700 071